Title : Pharmacological targeting of polyamine and hypusine biosynthesis reduces tumour activity of endometrial cancer.

Pub. Date : 2022 Jul

PMID : 35100927






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ODC is a MYC target gene and rate-limiting enzyme of polyamine biosynthesis and the FDA-approved anti-protozoan drug alpha-difluoromethylornithine (DFMO) inhibits ODC activity and induces polyamine depletion that leads to tumor growth arrest. Eflornithine ornithine decarboxylase 1 Homo sapiens
2 ODC is a MYC target gene and rate-limiting enzyme of polyamine biosynthesis and the FDA-approved anti-protozoan drug alpha-difluoromethylornithine (DFMO) inhibits ODC activity and induces polyamine depletion that leads to tumor growth arrest. Eflornithine ornithine decarboxylase 1 Homo sapiens
3 ODC is a MYC target gene and rate-limiting enzyme of polyamine biosynthesis and the FDA-approved anti-protozoan drug alpha-difluoromethylornithine (DFMO) inhibits ODC activity and induces polyamine depletion that leads to tumor growth arrest. Eflornithine ornithine decarboxylase 1 Homo sapiens
4 ODC is a MYC target gene and rate-limiting enzyme of polyamine biosynthesis and the FDA-approved anti-protozoan drug alpha-difluoromethylornithine (DFMO) inhibits ODC activity and induces polyamine depletion that leads to tumor growth arrest. Eflornithine ornithine decarboxylase 1 Homo sapiens
5 We show that the eIF5A1 is significantly upregulated in EC cells compared to control cells (p = 0.000038) and that combined pharmacological targeting of ODC and eIF5A hypusination with cytostatic drugs DFMO and N1-guanyl-1,7-diaminoheptane (GC7), respectively, reduces eIF5A1 activation and synergistically induces apoptosis in EC cells. Eflornithine ornithine decarboxylase 1 Homo sapiens